Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0417-2015Class II

MicroVue Bb Plus EIA is packaged as a kit which contains all reagent components to perform the test. In vitro...

Ortho-Clinical Diagnostics, Inc. / initiated 2014-10-16 / Terminated / root cause: design

Diagnostic Hybrids Inc began a recall of MicroVue Bb Plus EIA is packaged as a kit which contains all reagent components to perform the test. In vitro diagnostic on . FDA classified it as Class II and gives the reason as "Samples are quantitating incorrectly, with approximately 50% higher concentration values than previously reported and historically documented". As of , the recall status on record is Terminated, and MDM tags the root cause as design.

Recall record

Recall number
Z-0417-2015
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Ortho-Clinical Diagnostics, Inc.
Product
MicroVue Bb Plus EIA is packaged as a kit which contains all reagent components to perform the test. In vitro diagnostic.
Product code
JZH Factor B, Antigen, Antiserum, Control
Reason for recall
Samples are quantitating incorrectly, with approximately 50% higher concentration values than previously reported and historically documented.
Root cause tag
design
FDA root cause
Device Design
Action
Quidel sent an Urgent Medical Device Recall letter dated October 16, 2014, to all consignees. The letter identified the product, the problem, and the action to be taken by the customer. Customers were instructed to immediately review their inventory and determine if they have of the affected product. If so, they should remove it from their inventory and destroy it immediately by discarding it into their normal biomedical waste stream. Complete the enclosed Certificate of Destruction. Upon receipt of the Certificate of Destruction, Quidel, will then schedule their shipment of replacement product. If consignees further distributed the affected product, they should identify the customers and provide them with the Urgent Medical Device Recall. Consignees were instructed to monitor and reconcile the quarantine of product with the customers as this information may need to be provided to the authorities. For questions regarding this recall call 740-589-3300. For technical support consignees should contact [email protected] or call 800-874-1517.
Quantity in commerce
171
Distribution
Worldwide Distribution - USA, including AL, CO, CT, FL, KY, MN, NC, NV, OH, PA, and WA; and, the countries of Canada, China, India, and Switzerland.
Product codes and lots
Model Number A027; Lot Number 018186;  (self-affixed, EDMA Code: 12 01 02 04 00; Complement Component Bb)

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0417-2015
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0417-2015Class IITerminatedVoluntary: Firm initiated